Editorial
doi: 10.3803/EnM.2024.201.
Epub 2024 Apr 25.
The Levothyroxine Odyssey: Navigating the Path of Survivorship in Thyroid Cancer
Affiliations
- PMID: 38693818
- PMCID: PMC11066438
- DOI: 10.3803/EnM.2024.201
Item in Clipboard
Editorial
The Levothyroxine Odyssey: Navigating the Path of Survivorship in Thyroid Cancer
Endocrinol Metab (Seoul).
2024 Apr.
No abstract available
Conflict of interest statement
No potential conflict of interest relevant to this article was reported.
Similar articles
-
Chronic thyrotropin-suppressive therapy with levothyroxine and short-term overt hypothyroidism after thyroxine withdrawal are associated with undesirable cardiovascular effects in patients with differentiated thyroid carcinoma.Endocr Relat Cancer. 2004 Jun;11(2):345-56. doi: 10.1677/erc.0.0110345. Endocr Relat Cancer. 2004. PMID: 15163309
-
Pseudomalabsorption of levothyroxine: a case report.Endocr J. 2000 Feb;47(1):45-50. doi: 10.1507/endocrj.47.45. Endocr J. 2000. PMID: 10811292
-
Prediction of thyroid hormone supplementation after thyroid lobectomy.J Surg Res. 2015 Jan;193(1):273-8. doi: 10.1016/j.jss.2014.07.003. Epub 2014 Jul 5. J Surg Res. 2015. PMID: 25088372
-
Treatment of hypothyroidism with levothyroxine or a combination of levothyroxine plus L-triiodothyronine.Best Pract Res Clin Endocrinol Metab. 2015 Jan;29(1):57-75. doi: 10.1016/j.beem.2014.10.004. Epub 2014 Oct 25. Best Pract Res Clin Endocrinol Metab. 2015. PMID: 25617173 Review.
-
Levothyroxine for the Treatment of Subclinical Hypothyroidism and Cardiovascular Disease.Front Endocrinol (Lausanne). 2020 Oct 21;11:591588. doi: 10.3389/fendo.2020.591588. eCollection 2020. Front Endocrinol (Lausanne). 2020. PMID: 33193104 Free PMC article. Review.
References
-
- Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26:1–133. - PMC - PubMed
-
- Yu J, Kaur R, Ayeni FE, Eslick GD, Edirimanne S. Cardiovascular outcomes of differentiated thyroid cancer patients on long term TSH suppression: a systematic review and meta-analysis. Horm Metab Res. 2023;55:379–87. - PubMed
-
- Zhang H, Yang Y, Gao C, Tian L. Effect of thyroid-stimulating hormone suppression therapy on cardiac structure and function in patients with differentiated thyroid cancer after thyroidectomy: a systematic review and meta-analysis. Endocr Pract. 2024;30:177–86. - PubMed
-
- Ku EJ, Yoo WS, Lee EK, Ahn HY, Woo SH, Hong JH, et al. Effect of TSH suppression therapy on bone mineral density in differentiated thyroid cancer: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2021;106:3655–67. - PubMed
-
- Boucai L, Zafereo M, Cabanillas ME. Thyroid cancer: a review. JAMA. 2024;331:425–35. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
